In murine colitis models, IL-17A production from CD4+ T cells is protective because IL-17A directly suppresses the development of colitogenic Th1 cells via IL-17R expressed on activated CD4+ T cells (O'Connor et al. 2009). This evidence concerns the gene CD4 and colitis.